Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. | Sci Rep | 2023 | 37626132 | PubTator, text mining | PubMed |
| The role of Mycobacterium tuberculosis acetyltransferase and protein acetylation modifications in tuberculosis. | Front Cell Infect Microbiol | 2023 | 37560320 | PubTator, text mining | PubMed |
| Applications of multi-omics analysis in human diseases. | MedComm (2020) | 2023 | 37533767 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics. | Front Mol Biosci | 2023 | 37469704 | PubTator, text mining | PubMed |
| Nuclear DNA and Mitochondrial Damage of the Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Human Neuroblastoma Cells. | Chem Res Toxicol | 2023 | 37421305 | PubTator, text mining | PubMed |
| [Knockdown of ACC1 promotes migration of esophageal cancer cell]. | Zhonghua Zhong Liu Za Zhi | 2023 | 37355466 | PubTator, text mining | PubMed |
| The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma. | Front Oncol | 2023 | 37350934 | PubTator, text mining | PubMed |
| Hypoxia induced responses are reflected in the stromal proteome of breast cancer. | Nat Commun | 2023 | 37349288 | PubTator, text mining | PubMed |
| A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer. | Front Genet | 2023 | 37323657 | PubTator, text mining | PubMed |
| Contrasting Effects of Temperature on Human Arylamine N-Acetyltransferase and Acetyl Coenzyme A Hydrolase Activities. | Biochemistry | 2023 | 37318062 | PubTator, text mining | PubMed |
| Bladder cancer in young adults: Disease and treatment characteristics of patients treated at a tertiary cancer center. | Urol Ann | 2023 | 37304510 | PubTator, text mining | PubMed |
| Etiopathogenesis and Emerging Methods for Treatment of Vitiligo. | Int J Mol Sci | 2023 | 37298700 | PubTator, text mining | PubMed |
| Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study. | Cancers (Basel) | 2023 | 37296884 | PubTator, text mining | PubMed |
| Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy. | Front Oncol | 2023 | 37284197 | PubTator, text mining | PubMed |
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine. | EPMA J | 2023 | 37275549 | PubTator, text mining | PubMed |
| Investigation of N-Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen. | Pharmaceutics | 2023 | 37242713 | PubTator, text mining | PubMed |
| Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data. | Front Pharmacol | 2023 | 37234706 | PubTator, text mining | PubMed |
| Experimental Murine Models for Colorectal Cancer Research. | Cancers (Basel) | 2023 | 37174036 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome. | Eur J Hum Genet | 2023 | 37130971 | PubTator, text mining | PubMed |
| Mechanisms of NAT10 as ac4C writer in diseases. | Mol Ther Nucleic Acids | 2023 | 37128278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=5